CEREGUARD

USPTO USPTO 2001 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark CEREGUARD was filed as Word mark on 11/19/2001 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 03/23/2004. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details Last update: May 19, 2018

Trademark form Word mark
File reference 76340072
Register number 2824389
Application date November 19, 2001
Publication date December 30, 2003
Entry date March 23, 2004

Trademark owner

Archimedesweg 4
2333 CN Leiden, Nederland
NL

Trademark representatives

goods and services

5 PHARMACEUTICAL PREPARATIONS FOR MEDICAL, THERAPEUTIC AND/OR PROPHYLACTIC USE IN THE TREATMENT AND/OR PREVENTION OF DEFECTS TO THE CENTRAL NERVOUS SYSTEM AND/OR THE PERIPHERAL NERVOUS SYSTEM; AND DIAGNOSTIC PREPARATIONS FOR CLINICAL OR MEDICAL LABORATORY USE
40 TREATMENT OF PROTEIN-LIKE SUBSTANCES, NAMELY, CHEMICAL TREATMENT FOR MEDICAL USE, RESEARCH OR DIAGNOSTIC PURPOSES; TREATMENT OF PROTEIN-LIKE SUBSTANCES WITH CHARACTERISTICS THAT HAVE A POSITIVE INFLUENCE ON THE TREATMENT AND/OR PREVENTION OF DEFECTS TO THE CENTRAL NERVOUS SYSTEM AND/OR THE PERIPHERAL NERVOUS SYSTEM, NAMELY, CHEMICAL TREATMENT
42 SCIENTIFIC RESEARCH OF PROTEIN-LIKE SUBSTANCES WITH CHARACTERISTICS THAT HAVE A POSITIVE INFLUENCE ON THE TREATMENT AND/OR PREVENTION OF DEFECTS TO THE CENTRAL NERVOUS SYSTEM AND/OR THE PERIPHERAL NERVOUS SYSTEM; AND RESEARCH, NAMELY, SCIENTIFIC, CHEMICAL, MEDICAL, AND TESTING RESEARCH OF PROTEIN-LIKE SUBSTANCES WITH CHARACTERISTICS THAT HAVE A POSITIVE INFLUENCE ON THE TREATMENT AND/OR PREVENTION OF DEFECTS TO THE CENTRAL NERVOUS SYSTEM AND/OR THE PERIPHERAL NERVOUS SYSTEM FOR DIAGNOSTIC PURPOSES

ID: 1376340072